{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:13:49Z","timestamp":1778825629486,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270529"],"award-info":[{"award-number":["82270529"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371806"],"award-info":[{"award-number":["82371806"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070512"],"award-info":[{"award-number":["82070512"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171797"],"award-info":[{"award-number":["82171797"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470523"],"award-info":[{"award-number":["82470523"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ajg.2025.09.023","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:07:10Z","timestamp":1763014030000},"page":"51-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Depletion of FOXO4 promotes the development of nonalcoholic fatty liver disease by aggravating high-fat diet-induced liver injury by increasing SPP1 expression"],"prefix":"10.1016","volume":"27","author":[{"given":"Li","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanghui","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duane","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajg.2025.09.023_b0005","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cld.2023.01.001","article-title":"Nonalcoholic fatty liver disease: disease burden and disease awareness","volume":"27","author":"Golabi","year":"2023","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.ajg.2025.09.023_b0010","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajg.2025.09.023_b0015","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.ajg.2025.09.023_b0020","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/cvr\/cvad095","article-title":"Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options","volume":"119","author":"Grander","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ajg.2025.09.023_b0025","article-title":"Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)","volume":"13","author":"Rong","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajg.2025.09.023_b0030","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jconrel.2023.09.040","article-title":"Nonalcoholic fatty liver disease: current therapies and future perspectives in drug delivery","volume":"363","author":"Domingues","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.ajg.2025.09.023_b0035","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00018-019-03297-w","article-title":"Current perspective on the regulation of FOXO4 and its role in disease progression","volume":"77","author":"Liu","year":"2020","journal-title":"Cell Mol Life Sci"},{"issue":"Suppl 1","key":"10.1016\/j.ajg.2025.09.023_b0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jgh.12021","article-title":"Forkhead box class O transcription factors in liver function and disease","volume":"28","author":"Tikhanovich","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ajg.2025.09.023_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107572","article-title":"FOXO4 ameliorates alcohol-induced chronic liver injury via inhibiting NF-\u03baB and modulating gut microbiota in C57BL\/6J mice","volume":"96","author":"Sang","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ajg.2025.09.023_b0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clinbiochem.2018.07.003","article-title":"The multiple functions and mechanisms of osteopontin","volume":"59","author":"Icer","year":"2018","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ajg.2025.09.023_b0055","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/hep.31582","article-title":"Osteopontin takes center stage in chronic liver disease","volume":"73","author":"Song","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2025.09.023_b0060","article-title":"SPP1 and CXCL9 promote non-alcoholic steatohepatitis progression based on bioinformatics analysis and experimental studies","volume":"9","author":"Wang","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ajg.2025.09.023_b0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1053\/j.gastro.2023.03.228","article-title":"Macrophage-derived osteopontin (SPP1) protects from nonalcoholic steatohepatitis","volume":"165","author":"Han","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajg.2025.09.023_b0070","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166731","article-title":"Hepatocyte-specific CCAAT\/enhancer binding protein \u03b1 restricts liver fibrosis progression","volume":"134","author":"Yan","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajg.2025.09.023_b0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-0716-0958-3_9","article-title":"Targeted transgenic mice using CRISPR \/Cas9 technology","volume":"2214","author":"El Marjou","year":"2021","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ajg.2025.09.023_b0080","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.scib.2021.10.014","article-title":"Hepatic CDP-diacylglycerol synthase 2 deficiency causes mitochondrial dysfunction and promotes rapid progression of NASH and fibrosis","volume":"67","author":"Xu","year":"2022","journal-title":"Sci Bull (Beijing)"},{"key":"10.1016\/j.ajg.2025.09.023_b0085","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.cmet.2020.03.007","article-title":"TNFAIP3 interacting protein 3 overexpression suppresses nonalcoholic steatohepatitis by blocking TAK1 activation","volume":"31","author":"Liu","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.ajg.2025.09.023_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/nu11092062","article-title":"Indole-3-acetic acid alleviates nonalcoholic fatty liver disease in mice via attenuation of hepatic lipogenesis, and oxidative and inflammatory stress","volume":"11","author":"Ji","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ajg.2025.09.023_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/nu16060842","article-title":"Ginsenoside Rg(5) activates the LKB1\/AMPK\/mTOR signaling pathway and modifies the gut microbiota to alleviate nonalcoholic fatty liver disease induced by a high-fat diet","volume":"16","author":"Shi","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.ajg.2025.09.023_b0100","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2741\/4892","article-title":"Current treatment paradigms and emerging therapies for NAFLD\/NASH","volume":"26","author":"Raza","year":"2021","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.ajg.2025.09.023_b0105","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.1007\/s11033-023-08666-0","article-title":"Biomarkers of liver diseases","volume":"50","author":"Tamber","year":"2023","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.ajg.2025.09.023_b0110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases","volume":"27","author":"Samuel","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.ajg.2025.09.023_b0115","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3920196","article-title":"The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)","volume":"2020","author":"Tanase","year":"2020","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.ajg.2025.09.023_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/biom12060824","article-title":"NAFLD: mechanisms, treatments, and biomarkers","volume":"12","author":"Nassir","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ajg.2025.09.023_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415489","article-title":"Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment","volume":"23","author":"Guo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajg.2025.09.023_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118619","article-title":"Significance of MR\/OPN\/HMGB1 axis in NAFLD-associated hepatic fibrogenesis","volume":"264","author":"Tang","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.ajg.2025.09.023_b0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.lfs.2018.08.017","article-title":"Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: attention to the gut-vascular barrier dysfunction","volume":"209","author":"Cheng","year":"2018","journal-title":"Life Sci"},{"key":"10.1016\/j.ajg.2025.09.023_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154837","article-title":"Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus","volume":"125","author":"Wang","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.ajg.2025.09.023_b0145","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12041-016-0673-7","article-title":"Comparative analysis of gene expression profiles of OPN signaling pathway in four kinds of liver diseases","volume":"95","author":"Wang","year":"2016","journal-title":"J Genet"},{"key":"10.1016\/j.ajg.2025.09.023_b0150","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.aohep.2020.01.001","article-title":"Osteopontin - a potential biomarker of advanced liver disease","volume":"19","author":"Bruha","year":"2020","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.ajg.2025.09.023_b0155","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41598-022-04971-z","article-title":"Hepatic galectin-3 is associated with lipid droplet area in non-alcoholic steatohepatitis in a new swine model","volume":"12","author":"Herrera-Marcos","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajg.2025.09.023_b0160","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.nut.2018.12.001","article-title":"Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease","volume":"62","author":"Arendt","year":"2019","journal-title":"Nutrition"},{"key":"10.1016\/j.ajg.2025.09.023_b0165","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/liv.14464","article-title":"Impact of osteopontin on the development of non-alcoholic liver disease and related hepatocellular carcinoma","volume":"40","author":"Nardo","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.ajg.2025.09.023_b0170","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197925001327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197925001327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:49:13Z","timestamp":1778824153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197925001327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1687197925001327"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2025.09.023","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depletion of FOXO4 promotes the development of nonalcoholic fatty liver disease by aggravating high-fat diet-induced liver injury by increasing SPP1 expression","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2025.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V. on behalf of Pan-Arab Association of Gastroenterology.","name":"copyright","label":"Copyright"}]}}